Canada Spends Logo

Explore our Budget 2026 analysis

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

McMaster University

$120,000.00

Blood Group-Specific vs. Blood Group O Red Blood Cell Transfusions in Critically Ill neonates: A Pilot Randomized Trial

FY 2025-26

Summary
Newborns in intensive care often need red blood cell (RBC) transfusions as part of medical care. Many hospitals use blood group type O RBC routinely as it is often hard to determine the baby's blood type accurately, and type O blood can be used for anyone, known as the 'universal donor'. However, it is possible that small amounts of antibodies in the type O blood bag can cause problems in the baby including low blood counts, inflammation and reactions in body's defense system. Previous research suggests that using type O RBC for non-O individuals (A, B or AB) can subtly increase the risk of death. Even a small harmful effect could have important consequences on sick newborns, so it is important for us to study this before more babies are harmed. We will review literature to identify what is already known about RBC transfusions in newborns and conduct a survey to gather data on key areas of blood transfusion practices in different hospitals across Canada. We will also design and conduct a small-scale feasibility study (also known as pilot trial). This would be a randomized clinical trial, meaning babies will be randomly assigned to receive either blood group-specific RBC that matches their own blood type or type O RBC irrespective of their blood type, both of which are accepted and currently being used. This pilot trial will look at whether it is feasible to enroll enough babies correctly and collect enough data in a future larger trial. We will also measure clinical outcomes including death rates and transfusion complications. This project will help identify current knowledge gaps and future research scope, practice variations in newborns' RBC transfusions across Canada highlighting areas requiring standardization. Ultimately, the project will inform the best design methods for a larger clinical trial. Once this program is completed, if type O RBCs are associated with harms, our research could lead to change in current blood transfusion practice for babies.
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
559329
Name
Hossain Fatema
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
DT2 (Health services and population health research) CGRS Doctoral
Projecttitle
Blood Group-Specific vs. Blood Group O Red Blood Cell Transfusions in Critically Ill neonates: A Pilot Randomized Trial
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Blood Group-Specific Transfusion; Clinical Trial; Critically Ill Neonates; Group O Blood Transfusion; Pilot Study; Randomized; Red Blood Cell Transfusion
Abstract
Newborns in intensive care often need red blood cell (RBC) transfusions as part of medical care. Many hospitals use blood group type O RBC routinely as it is often hard to determine the baby's blood type accurately, and type O blood can be used for anyone, known as the 'universal donor'. However, it is possible that small amounts of antibodies in the type O blood bag can cause problems in the baby including low blood counts, inflammation and reactions in body's defense system. Previous research suggests that using type O RBC for non-O individuals (A, B or AB) can subtly increase the risk of death. Even a small harmful effect could have important consequences on sick newborns, so it is important for us to study this before more babies are harmed. We will review literature to identify what is already known about RBC transfusions in newborns and conduct a survey to gather data on key areas of blood transfusion practices in different hospitals across Canada. We will also design and conduct a small-scale feasibility study (also known as pilot trial). This would be a randomized clinical trial, meaning babies will be randomly assigned to receive either blood group-specific RBC that matches their own blood type or type O RBC irrespective of their blood type, both of which are accepted and currently being used. This pilot trial will look at whether it is feasible to enroll enough babies correctly and collect enough data in a future larger trial. We will also measure clinical outcomes including death rates and transfusion complications. This project will help identify current knowledge gaps and future research scope, practice variations in newborns' RBC transfusions across Canada highlighting areas requiring standardization. Ultimately, the project will inform the best design methods for a larger clinical trial. Once this program is completed, if type O RBCs are associated with harms, our research could lead to change in current blood transfusion practice for babies.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Hossain, Fatema
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~
McMaster University - $120,000 Grant (2025-26) | Canada Spends